...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Validation of Hemochroma PLUS: A Point of Care Testing Device for Haemoglobin Estimation
【24h】

Validation of Hemochroma PLUS: A Point of Care Testing Device for Haemoglobin Estimation

机译:Hemochroma PLUS的验证:血红蛋白估计的即时检验设备

获取原文
           

摘要

Anaemia is a major public health challenge in India. Advent of Point of Care (POC) testing devices for haemoglobin estimation may be useful in the field settings, albeit after proper validation of these devices.Aim: To assess the validity of Hemochroma PLUS in haemoglobin estimation by comparing it with an automated laboratory analyser in rural Indian context.Materials and Methods: A cross-sectional study was conducted at a tertiary care rural teaching hospital during November-December 2017. Adults visiting the out-patient laboratory collection unit for a haemogram test were included in the study. Venous blood samples were collected by trained phlebotomists and tested using autoanalyser in the laboratory. Capillary blood samples were collected by a trained study coordinator using a lancet (Ez-life) and tested on a Hemochroma PLUS device. Haemoglobin measurement by both methods was compared using Bland-Altman analysis. The analysis was performed using STATA (14.2).Results: A total of 100 (53 females and 47 males) adults participated in the study. Mean (SD) age of the participants was 44.62 (16.92) years. Bland-Altman analysis revealed that the mean difference (95% confidence limits) was 0.3 (-2.0, 2.7) gm/dL. Hemochroma PLUS was found to have sensitivity of 84.90% and specificity of 82.98% in identifying anaemia.Conclusion: Hemochroma PLUS showed good agreement with the cell counter in current study. Further studies may be undertaken in different study populations and study settings. Hemochroma PLUS, has a potential as a POC tool for community-based anaemia screening and evaluation of anaemia control programmes.
机译:贫血是印度的主要公共卫生挑战。尽管对这些设备进行了适当的验证,但用于现场血红蛋白估计的即时检验(POC)测试设备的出现可能在现场设置中很有用。目标:通过与自动仪器比较,评估Hemochroma PLUS在血红蛋白估计中的有效性材料与方法:2017年11月至12月在一家三级农村教学医院进行了一项横断面研究。其中,成人包括门诊实验室采集单位进行血红蛋白检查的患者。研究。由经过训练的抽血医生收集静脉血样,并在实验室中使用自动分析仪进行测试。训练有素的研究协调员使用柳叶刀(Ez-life)收集毛细血管血样,并在Hemochroma PLUS设备上进行测试。使用Bland-Altman分析比较了两种方法的血红蛋白测量值。使用STATA(14.2)进行分析。结果:共有100位成年人(53位女性和47位男性)参加了研究。参与者的平均(SD)年龄为44.62(16.92)岁。 Bland-Altman分析显示,平均差异(95%置信限)为0.3(-2.0,2.7)gm / dL。发现Hemochroma PLUS在鉴定贫血方面具有84.90%的敏感性和82.98%的特异性。结论:Hemochroma PLUS与当前的细胞计数器显示出良好的一致性。可以在不同的研究人群和研究环境中进行进一步的研究。 Hemochroma PLUS有潜力作为POC工具,用于社区贫血筛查和贫血控制计划评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号